These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11641836)

  • 1. Tuberculosis recurrence after directly observed therapy.
    Hill AR
    Clin Infect Dis; 2001 Nov; 33(10):1797-8. PubMed ID: 11641836
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of directly observed treatment short course (DOTS) in a case of pulmonary tuberculosis with hyperuricemia.
    Gowrinath K
    Indian J Tuberc; 2009 Apr; 56(2):108. PubMed ID: 19810595
    [No Abstract]   [Full Text] [Related]  

  • 3. Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome.
    Rusen ID; Aït-Khaled N; Alarcón E; Billo N; Bissell K; Boillot F; Caminero J; Chiang CY; Clevenbergh P; Dhliwayo P; Dlodlo R; Enarson DA; Ferroussier O; Fujiwara PI; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Trébucq A; Van Deun A; Wilson N
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):120-1. PubMed ID: 17263279
    [No Abstract]   [Full Text] [Related]  

  • 4. World Health Organization fact sheet. Tuberculosis.
    World Health Organization
    Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuberculosis control: critical lessons learnt.
    Frieden TR
    Indian J Med Res; 2005 Mar; 121(3):140-2. PubMed ID: 15802753
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience in tuberculosis treatment through directly observed therapy short course in health centres and communities in Cambodia.
    Khieu K; Ito K; Hamajima N
    Public Health; 2007 Sep; 121(9):696-9. PubMed ID: 17540421
    [No Abstract]   [Full Text] [Related]  

  • 7. Directly observed treatment for tuberculosis.
    Garner P; Volmink J
    BMJ; 2003 Oct; 327(7419):823-4. PubMed ID: 14551066
    [No Abstract]   [Full Text] [Related]  

  • 8. TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa.
    Kharsany AB; Connolly C; Olowolagba A; Abdool Karim SS; Abdool Karim Q
    Trop Doct; 2006 Jan; 36(1):23-5. PubMed ID: 16483424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and post-directly observed treatment era in the management of TB: a teachiing hospital experience.
    Daniel OJ
    Trop Doct; 2006 Jul; 36(3):163-5. PubMed ID: 16884624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient's awareness and some behavioural issues related to TB and DOTS.
    Pathak P; Haider S; Kashyap V; Singh SB; Lal PK
    Indian J Public Health; 2008; 52(4):230-1. PubMed ID: 19189830
    [No Abstract]   [Full Text] [Related]  

  • 11. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT; Ye LX; Shi LY; Xiao AQ; Hou SY; Wang W; Ye JJ; Tang SW; Zhao HH; Xu HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):658-60. PubMed ID: 15555385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The eventual 6th and 7th elements of DOTS: a metaphor.
    Danusantoso H
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):403. PubMed ID: 12729349
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
    Ormerod LP; Horsfield N; Green RM
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):662-5. PubMed ID: 12150476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence following antitubercular therapy].
    Fischer P
    Z Arztl Fortbild (Jena); 1986; 80(16):683-4. PubMed ID: 3788221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relapses in pulmonary tuberculosis. Value of the case history for the selection of the best retreatment regimen].
    Pilheu JA; de Salvo MC; Gnecco V; Giannattasio J; Hoffman M
    Medicina (B Aires); 1982; 42(4):389-95. PubMed ID: 15171020
    [No Abstract]   [Full Text] [Related]  

  • 17. DOTS progress in India: 1995-2002.
    Khatri GR
    Tuberculosis (Edinb); 2003; 83(1-3):30-4. PubMed ID: 12758186
    [No Abstract]   [Full Text] [Related]  

  • 18. An effective compromise.
    Reichman LB
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1061. PubMed ID: 16229215
    [No Abstract]   [Full Text] [Related]  

  • 19. Can DOTS improve quality of life among patients with pulmonary tuberculosis?
    Chung WS; Li CR
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):425-6. PubMed ID: 23407236
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results obtained in the treatment of pulmonary tuberculosis with chemo-antibiotic therapy in the decade 1959-1968].
    Fronzaroli L; Del Balzo E
    Lotta Tuberc; 1971; 41(4):581-9. PubMed ID: 5291678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.